AbbVie | Créances Commerciales



Trade Debtors Changement Date
AbbVie USD 10.92B 553M 2024-12
Abbott USD 9.67B 2.74B 2025-03
ALKERMES USD 394.72M 24.54M 2024-12
Amgen USD 6.78B 535M 2024-12
AstraZeneca USD 14.82B 16M 2025-03
Biogen USD 1.87B 119.3M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Eisai JPY 235.64B 40.42B 2024-12
Eli Lilly USD 14B 727.8M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
J&J USD 16.02B 1.18B 2025-03
Medtronic USD 6.12B 145M 2025-01
Merck USD 11.12B 1.06B 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Pacira USD 113.3M 12.65M 2024-12
Perrigo USD 686.2M 99.7M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
UCB EUR 1.42B 132M 2024-06
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
United Therapeutics USD 322M 42.7M 2025-03
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12
Zoetis USD 1.32B 95M 2024-12



AbbVie Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.